TY - JOUR
T1 - The Accelerated Child Survival and Development programme in west Africa
T2 - a retrospective evaluation
AU - Bryce, Jennifer
AU - Gilroy, Kate
AU - Jones, Gareth
AU - Hazel, Elizabeth
AU - Black, Robert E.
AU - Victora, Cesar G.
N1 - Funding Information:
ACSD funding from CIDA ranged from $1·5 million in Benin to $3·8 million in Ghana, and the duration of funding from 2002–04 in Benin to 2001–05 in Mali. UNICEF staff in all countries reported that ACSD programme funds were supplemented by additional funds from the UNICEF country budgets and other partners, but specific amounts of additional funding were not able to be documented by the external evaluation. All three countries continued to implement the ACSD activities after the end of CIDA funds with support from UNICEF country budgets and other partners.
PY - 2010
Y1 - 2010
N2 - Background: UNICEF implemented the Accelerated Child Survival and Development (ACSD) programme in 11 west African countries between 2001 and 2005 to reduce child mortality by at least 25% by the end of 2006. We undertook a retrospective evaluation of the programme in Benin, Ghana, and Mali. Methods: We used data from Demographic and Health Surveys and Multiple Indicator Cluster Surveys to compare changes in coverage for 14 ACSD interventions, nutritional status (stunting and wasting), and mortality in children younger than 5 years in the ACSD focus districts with those in the remainder of every country (comparison areas), after excluding major metropolitan areas. Findings: Mortality in children younger than 5 years decreased in ACSD areas by 13% in Benin (absolute decrease 18 deaths per 1000 livebirths, p=0·12), 20% in Ghana (21 per 1000 livebirths, p=0·10), and 24% in Mali (63 per 1000 livebirths, p<0·0001), but these decreases were not greater than those in comparison areas in Benin (25%; absolute decrease 36 deaths per 1000 livebirths, p=0·15) or Mali (31%; 76 per 1000 livebirths, p=0·30; comparison data not available for Ghana). ACSD districts showed significantly greater increases than did comparison areas in coverage for preventive interventions delivered through outreach and campaign strategies in Ghana and Mali, but not Benin. Coverage in ACSD areas for correct treatment of childhood pneumonia, diarrhoea, and malaria did not differ significantly from before to after programme implementation in Benin and Mali, but decreased significantly in Ghana for malaria (from 78% to 53%, p<0·0001) and diarrhoea (from 39% to 28%, p=0·05). We recorded no significant improvements in nutritional status attributable to ACSD in the three countries. Interpretation: The ACSD project did not accelerate child survival in Benin and Mali focus districts relative to comparison areas, probably because coverage for effective treatment interventions for malaria and pneumonia were not accelerated, causes of neonatal deaths and undernutrition were not addressed, and stock shortages of insecticide-treated nets restricted the potential effect of this intervention. Changes in policy and nationwide programme strengthening may have benefited from inputs by UNICEF and other partners, making an acceleration effect in the ACSD focus districts difficult to capture. Funding: UNICEF, Canadian International Development Agency, Coordenação de Aperfeiçoamento de Pessoal do Nível Superior (Brazil), and Fulbright Fellowship.
AB - Background: UNICEF implemented the Accelerated Child Survival and Development (ACSD) programme in 11 west African countries between 2001 and 2005 to reduce child mortality by at least 25% by the end of 2006. We undertook a retrospective evaluation of the programme in Benin, Ghana, and Mali. Methods: We used data from Demographic and Health Surveys and Multiple Indicator Cluster Surveys to compare changes in coverage for 14 ACSD interventions, nutritional status (stunting and wasting), and mortality in children younger than 5 years in the ACSD focus districts with those in the remainder of every country (comparison areas), after excluding major metropolitan areas. Findings: Mortality in children younger than 5 years decreased in ACSD areas by 13% in Benin (absolute decrease 18 deaths per 1000 livebirths, p=0·12), 20% in Ghana (21 per 1000 livebirths, p=0·10), and 24% in Mali (63 per 1000 livebirths, p<0·0001), but these decreases were not greater than those in comparison areas in Benin (25%; absolute decrease 36 deaths per 1000 livebirths, p=0·15) or Mali (31%; 76 per 1000 livebirths, p=0·30; comparison data not available for Ghana). ACSD districts showed significantly greater increases than did comparison areas in coverage for preventive interventions delivered through outreach and campaign strategies in Ghana and Mali, but not Benin. Coverage in ACSD areas for correct treatment of childhood pneumonia, diarrhoea, and malaria did not differ significantly from before to after programme implementation in Benin and Mali, but decreased significantly in Ghana for malaria (from 78% to 53%, p<0·0001) and diarrhoea (from 39% to 28%, p=0·05). We recorded no significant improvements in nutritional status attributable to ACSD in the three countries. Interpretation: The ACSD project did not accelerate child survival in Benin and Mali focus districts relative to comparison areas, probably because coverage for effective treatment interventions for malaria and pneumonia were not accelerated, causes of neonatal deaths and undernutrition were not addressed, and stock shortages of insecticide-treated nets restricted the potential effect of this intervention. Changes in policy and nationwide programme strengthening may have benefited from inputs by UNICEF and other partners, making an acceleration effect in the ACSD focus districts difficult to capture. Funding: UNICEF, Canadian International Development Agency, Coordenação de Aperfeiçoamento de Pessoal do Nível Superior (Brazil), and Fulbright Fellowship.
UR - http://www.scopus.com/inward/record.url?scp=76349097110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=76349097110&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(09)62060-2
DO - 10.1016/S0140-6736(09)62060-2
M3 - Article
C2 - 20071020
AN - SCOPUS:76349097110
SN - 0140-6736
VL - 375
SP - 572
EP - 582
JO - The Lancet
JF - The Lancet
IS - 9714
ER -